|
|
Volumn 22, Issue 5, 1999, Pages 372-373
|
|
Treatment options for advanced colorectal cancer continue to improve
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (3,4 DICHLOROPHENYL) 3 (2,3 DIHYDROBENZOFURAN 5 YLSULFONYL)UREA;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BIZELESIN;
CAPECITABINE;
FLUOROPYRIMIDINE DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
ONYX 015;
ORZEL;
OXALIPLATIN;
RALTITREXED;
THYMIDYLATE SYNTHASE INHIBITOR;
UFT;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
BOLUS INJECTION;
BREAST CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
COLORECTAL CANCER;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG INFUSION;
DRUG RESEARCH;
EDITORIAL;
FEBRILE NEUTROPENIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MEDICAL LITERATURE;
MUCOSA INFLAMMATION;
ORAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
|
|
EID: 0032757080
PISSN: 0378584X
EISSN: None
Source Type: Journal
DOI: 10.1159/000026985 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|